Show simple item record

dc.contributor.authorBrown, SMen
dc.contributor.authorSneyd, JRen

Nitrous oxide is an N-methyl--aspartate receptor antagonist and may reduce the incidence of chronic post-surgical pain. • Nitrous oxide oxidizes Vitamin B12 and can precipitate sub-acute combined degeneration of the cord with chronic use or in patients with folate/B12 deficiency. • Nitrous oxide expands air spaces and is contraindicated in patients with pneumothorax or recent (up to 4–6 weeks) ocular surgery using intraocular gas. • Nitrous oxide has global warming and ozone depletion potential and its concentration in the theatre environment is regulated. • The ENIGMA-II trial showed that nitrous oxide does not increase the risk of death or cardiovascular complications.

dc.format.extent1 - 5 (5)en
dc.titleNitrous oxide in modern anaesthetic practiceen
dc.typeJournal Article
plymouth.journalBJA Educationen
plymouth.organisational-group/Plymouth/00 Groups by role
plymouth.organisational-group/Plymouth/00 Groups by role/Professional Services staff
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
dc.rights.embargoperiodNot knownen
rioxxterms.typeJournal Article/Reviewen

Files in this item


This item appears in the following Collection(s)

Show simple item record

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV